Imfinzi 500 MG/10 ML vial 10ML
Ended Awarded Last action
- Contract number
- SPE2DR26F9GH8
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $27,954
Award facts
- Contract value 100% obligated
- $27,953.90 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a $27,953.90 firm fixed-price delivery order to AmerisourceBergen Drug Corp for IMFINZI 500 mg/10 mL vials on December 17, 2025. This non-competitive, competitively awarded delivery order is scheduled for completion by January 9, 2026, with performance taking place at the contractor's corporate headquarters in Conshohocken, Pennsylvania. IMFINZI (durvalumab) is an immunotherapy medication used in cancer treatment, and this order supports the DLA's medical supply chain requirements for military and federal healthcare systems.
This delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a $999.99 billion ceiling value through December 2026. As a major pharmaceutical distributor and critical federal healthcare vendor, AmerisourceBergen maintains an extensive portfolio of pharmaceutical and medical supply deliveries across multiple therapeutic domains to support military healthcare programs worldwide. The IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply brand-name and generic drugs, specialty medications, vaccines, and medical supplies to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Quick answers
Who was awarded contract SPE2DR26F9GH8?
SPE2DR26F9GH8 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 17, 2025.
How much is contract SPE2DR26F9GH8 worth?
The government has obligated $27,954 on SPE2DR26F9GH8.
Is contract SPE2DR26F9GH8 an order under another contract?
Yes. SPE2DR26F9GH8 is a delivery order under SPE2DR25D2206, an indefinite delivery contract.
Was contract SPE2DR26F9GH8 competed?
The extent of competition for SPE2DR26F9GH8 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award